SCHEMBL4500632

SCHEMBL4500632

Cc1c(C(=O)c2ccc(N)c(C(=O)O)c2)c2ccccn2c1-c1cccc(OCCOCCOCCOCCOc2cccc(-c3c(C)c(C(=O)c4ccc(N)c(C(=O)O)c4)c4ccccn34)c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 4/20 0.40
PTGDR Q13258 1/20 0.37
MEN1 O00255 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 2/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
LMNA P02545 2/20 0.36
PPARG P37231 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
DHODH Q02127 1/20 0.36
MAPK1 P28482 1/20 0.35
CHEK1 O14757 1/20 0.35
CHEK2 O96017 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4509038 1.00 ALDH1A1 (0.40) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL4506225 0.91 RARB (0.40) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL1573287 0.91 RARB (0.40) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL4496163 0.87 KMT2A (0.42) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL4509036 0.85 MAPT (0.41) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL4500629 0.85 MAPT (0.41) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL1573418 0.85 KMT2A (0.41) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL1573317 0.84 ALDH1A1 (0.38) ALDH1A1KMT2AMAPTPTGDRMEN1
SCHEMBL4504205 0.84 ALDH1A1 (0.39) ALDH1A1KMT2AMAPTMEN1L3MBTL1
SCHEMBL4509090 0.84 ALDH1A1 (0.39) ALDH1A1KMT2AMAPTMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 US claimed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 US claimed
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 ALDH1A1 1044/4885KMT2A 3395/4885MAPT 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.